Ainos partners with NEXCOM to integrate AI Nose into industrial edge computing

SAN DIEGO - Ainos, Inc. (NASDAQ:AIMD), a micro-cap technology company currently trading at $3.94 with a market capitalization of $18.8 million, announced Tuesday a strategic partnership with NEXCOM International Co., Ltd. to integrate its AI Nose technology into NEXCOM’s industrial edge computing platforms.

Under the agreement, Ainos will provide AI Nose hardware and software for incorporation into NEXCOM’s edge AI and automation systems. The integration aims to enable real-time environmental sensing across manufacturing and industrial applications. According to InvestingPro data, Ainos maintains impressive gross profit margins of 82%, though the company is not yet profitable.

The companies plan to jointly develop and market solutions combining Ainos’ SmellTech and Smell Language Model with NEXCOM’s Industry 4.0 infrastructure to support monitoring, maintenance, and operations functions. The partnership comes as Ainos shows strong market momentum, with its stock delivering a 72.81% return year-to-date.

"Our partnership with NEXCOM marks another key step in scaling AI Nose across industrial environments," said Eddy Tsai, Chairman, President, and CEO of Ainos, in the press release.

NEXCOM, founded in 1992, develops edge computing platforms and AIoT solutions with 1,200 employees worldwide. The company serves customers in industrial automation, robotics, transportation, smart city, and healthcare sectors.

The collaboration expands Ainos’ industrial partner ecosystem, which includes companies in semiconductors, automation, and robotics. According to the company statement, this partnership supports Ainos’ strategy to commercialize its AI Nose globally through a service model.

AI Nose technology digitizes scent using MEMS sensor arrays and AI algorithms, detecting scent at parts-per-billion sensitivity. The system converts scent data into what the company calls "Smell ID" and interprets scent patterns through its proprietary Smell Language Model.

Ainos (NASDAQ:AIMD) describes itself as a dual-platform AI and biotech company working in smell technology and immune therapeutics.

The information in this article is based on a company press release. Investors interested in deeper analysis can access 12 additional InvestingPro Tips and comprehensive financial metrics, including Fair Value estimates and financial health scores.

In other recent news, Ainos, Inc. has transitioned to the Technology Hardware, Storage & Peripherals sector under the Global Industry Classification Standard, effective October 1, 2025. This reclassification reflects the company’s shift from biotechnology to focus on AI-powered scent digitization technology. Additionally, Ainos has secured seven new patents for its AI Nose digital olfaction platform in Europe, Germany, Taiwan, and China, bringing its total to 123 active patents globally. The company also filed a prospectus supplement with the SEC to offer up to $874,496 in additional common stock through an at-the-market offering agreement with H.C. Wainwright & Co., LLC. In a significant development, Ainos announced a $2.1 million order for its AI Nose platform with ASE Technology Holding Co., Ltd., marking its first commercial success in semiconductor manufacturing. This deal involves deploying 1,400 AI Nose units across ASE’s manufacturing sites in Taiwan. These developments highlight Ainos’ ongoing expansion and innovation in the field of digital olfaction technology.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.